What COVID taught us about exponential diversity

Authored by Chantal Free, Chief Executive Officer, Capita Portfolio, Capita Plc

Long before COVID-19, we had known and accepted that diversity is a crucial element to success. Mountains of research have proven the value of diversity at every level, from the individual to the team to the corporation. This insight by Capita, explores how exponential diversity can lead to better products, services and being better citizens.
 
Chantal Free, Chief Executive Officer for People Solutions at Capita, explains how more diverse teams are more likely to produce products with exponential growth potential. Companies with higher levels of diversity are more likely to return higher profits. Even at the leadership levels, female-led companies are both steadier and more profitable over time.
 
Other key areas of discussion include:
  • Embracing exponential diversity
  • A better model for diversity
  • After COVID-19: exponential diversity, resilience and growth

Share this with your Community



Contributor
Chantal Free
Chief Executive Officer, Capita Portfolio
Capita Plc


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

Employee Happiness in the Age of AI

In this report, AlixPartners and Darwin X argue that retail consistently trails other industries on employee happiness, and that closing that gap is not just a people issue, but a prerequisite for competing in the ag...


Click here to download this insight

VIEWPOINTS | Making the Leap from CPO to NED

Tea Colaianni MBE's career began in Brussels as a lawyer before deciding  she wanted to be in the driving seat. "I didn't want just to be advising companies on what to do: I wanted to do stuff,...


The Future of Executive Leadership and High Performance

Andrew Darfoor, SID, Post Office & Board Mentor at Criticaleye, and Jodene Young, Chief People Officer at the National Physical Laboratory (NPL), join Bridgette Hall, Senior Editor at Criticaleye, for a discussio...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 60




NATS NatWest Group CrowdStrike Canaccord Genuity Group Inc Legal & General Drax Group plc AlixPartners GlaxoSmithKline plc Stream Lightsource bp E.ON UK Global Payments LACE Partners London Stock Exchange Group Hitachi Solutions Southern Water Rolls-Royce British Land Aldermore Group Mayborn Group